January 1, 2018The EARLY Trial was looking to determine the Efficacy and safety of atabecestat in participants who are Asymptomatic at Risk…
February 24, 2017Those identified to have a potential increased risk for memory loss caused by Alzheimer’s disease were referred from the APT…
